Lassen MCH, Ostrominski JW, Inzucchi SE, Claggett BL, et al. Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial. Eur J Heart Fail 2024 May 15. doi: 10.1002/ejhf.3269.
PMID: 38745498